BIONET Therapeutics Corp. (TPEX:7808)

BIONET Therapeutics Statistics

Total Valuation

TPEX:7808 has a market cap or net worth of TWD 3.80 billion. The enterprise value is 2.67 billion.

Market Cap	3.80B
Enterprise Value	2.67B

Important Dates

The last earnings date was Wednesday, September 17, 2025.

Earnings Date	Sep 17, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:7808 has 70.00 million shares outstanding. The number of shares has increased by 81.39% in one year.

Current Share Class	70.00M
Shares Outstanding	70.00M
Shares Change (YoY)	+81.39%
Shares Change (QoQ)	+7.66%
Owned by Insiders (%)	4.12%
Owned by Institutions (%)	n/a
Float	67.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	35.97
PB Ratio	3.02
P/TBV Ratio	3.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-26.56
EV / Sales	25.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.80

Financial Position

The company has a current ratio of 29.41, with a Debt / Equity ratio of 0.00.

Current Ratio	29.41
Quick Ratio	28.40
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -9.23% and return on invested capital (ROIC) is -6.77%.

Return on Equity (ROE)	-9.23%
Return on Assets (ROA)	-6.56%
Return on Invested Capital (ROIC)	-6.77%
Return on Capital Employed (ROCE)	-9.37%
Revenue Per Employee	1.45M
Profits Per Employee	-1.38M
Employee Count	73
Asset Turnover	0.09
Inventory Turnover	3.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	51.21
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.13
Average Volume (20 Days)	197,648

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:7808 had revenue of TWD 105.67 million and -100.46 million in losses. Loss per share was -1.49.

Revenue	105.67M
Gross Profit	20.23M
Operating Income	-118.09M
Pretax Income	-100.46M
Net Income	-100.46M
EBITDA	-112.58M
EBIT	-118.09M
Loss Per Share	-1.49

Balance Sheet

The company has 1.14 billion in cash and 4.60 million in debt, giving a net cash position of 1.13 billion or 16.18 per share.

Cash & Cash Equivalents	1.14B
Total Debt	4.60M
Net Cash	1.13B
Net Cash Per Share	16.18
Equity (Book Value)	1.26B
Book Value Per Share	17.96
Working Capital	1.16B

Cash Flow

In the last 12 months, operating cash flow was -120.53 million and capital expenditures -59.77 million, giving a free cash flow of -180.30 million.

Operating Cash Flow	-120.53M
Capital Expenditures	-59.77M
Free Cash Flow	-180.30M
FCF Per Share	-2.58

Margins

Gross margin is 19.15%, with operating and profit margins of -111.75% and -95.07%.

Gross Margin	19.15%
Operating Margin	-111.75%
Pretax Margin	-95.07%
Profit Margin	-95.07%
EBITDA Margin	-106.54%
EBIT Margin	-111.75%
FCF Margin	n/a

Dividends & Yields

TPEX:7808 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-81.39%
Shareholder Yield	n/a
Earnings Yield	-2.64%
FCF Yield	-4.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:7808 has an Altman Z-Score of 46.83 and a Piotroski F-Score of 1.

Altman Z-Score	46.83
Piotroski F-Score	1